NEW DELHI: The Subject Matter Expert Committee (SEC) of the national drug regulator is likely to hold a meeting with Bharat Biotech on Saturday to consider your Covid-19 vaccine applicant, Covaxin. The committee constituted by the Central Organization for the Control of Medicines Standards on Friday had held that the …
Read More »
MUMBAI: Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as the Phase 3 stage of the study has now started. The adverse event occurred in a 35-year-old participant with no comorbidities, who was part of the Phase 1 trials in August, …
Read More »
MUMBAI: Hyderabad-based Bharat Biotech’s potential Covid-19 vaccine reported a serious adverse event during clinical trials in August, even as the Phase 3 stage of the study has now started. The adverse event occurred in a 35-year-old participant with no comorbidities, who was part of the Phase 1 trials in August, …
Read More »